Related Experiment Video

Updated: Jun 28, 2026

Gene Expression Analysis of Endothelial Cells Exposed to Shear Stress Using Multiple Parallel-plate Flow Chambers
08:50

Gene Expression Analysis of Endothelial Cells Exposed to Shear Stress Using Multiple Parallel-plate Flow Chambers

Published on: October 21, 2018

Peripheral blood gene expression profiling for cardiovascular disease assessment

Hamza Aziz1, Aimee Zaas, Geoffrey S Ginsburg

  • 1School of Medicine, Duke University, Durham, USA.

Genomic Medicine
|October 17, 2008
PubMed

Insights

Whole blood gene expression profiling offers insights into cardiovascular disease mechanisms and patient stratification. This genomic approach enhances prediction of cardiovascular events, improving patient outcomes.

Area of Science:

  • Cardiovascular Science
  • Genomics
  • Molecular Medicine

Background:

  • Whole blood gene expression profiling can reveal dynamic disease state changes and underlying mechanisms.
  • Previous studies in animal models demonstrated proof of concept for this approach.
  • Translating this to human cardiovascular disease is crucial for developing better diagnostic and prognostic tools.

Purpose of the Study:

  • To review the applications of whole blood gene expression profiling in cardiovascular science.
  • To highlight its potential in understanding complex cardiovascular diseases.
  • To showcase its utility in developing improved diagnostic and prognostic indicators.

Main Methods:

  • Review of existing studies on whole blood gene expression profiling in human cardiovascular diseases.
  • Analysis of genomic signatures for patient classification and event prediction.
  • Focus on complex conditions including atherosclerosis, hypertension, myocardial infarction, thromboembolism, aortic aneurysm, and heart transplant.

Main Results:

  • Genomic signatures can classify cardiovascular disease patients into finer categories based on molecular architecture.
  • This approach offers more accurate prediction of cardiovascular events compared to current techniques.
  • Demonstrated potential across a spectrum of cardiovascular conditions.

Conclusions:

  • Whole blood gene expression profiling is a powerful tool in cardiovascular science.
  • It aids in understanding disease complexity and improving patient stratification.
  • This technology promises enhanced diagnostic and prognostic capabilities for cardiovascular diseases.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...